
2023 Speakers
2023 Speakers

Robert L. Avery, MD
California Retina Consultants

Laurent Attias
Executive Committee, SVP, Corporate Development Strategy, BD&L and M&A, Alcon

Caroline Baumal, MD
Chief Medical Officer, Apellis Pharmaceuticals, Inc.

Kevin Cady
President & CEO, OnPoint Vision Inc.

Chris Calcaterra
Executive Vice President, Global Commercial Operations, Glaukos Corporation

Tara Capalbo
General Manager, Glaucoma, Allergan, an AbbVie Company

Bill Carpou
CEO, Octane

Marie Csete MD, PhD
CEO, OkuloVision

Robert J. Dempsey
Chief Executive Officer, President, AsclepiX Therapeutics, Inc

Lloyd Diamond
Chief Executive Officer, PIXIUM VISION

Andrew Douglas
Partner, Knobbe Martens

Megan Driscoll
CEO & Founder, EvolveMKD

Daniel Durrie, MD
Chairman, iOR Partners, Founder, Durrie Vision

David Esposito
CEO, ONL Therapeutics

Warren Foust
Chief Operating Officer, STAAR Surgical

Sanjeev Ganatra
Chief Commercial Officer, iuvo Biosciences

Michael Garanzini
Senior Director, Marketing, Sun Ophthalmics

Andrew Gitkin
Vice Chairman, Healthcare Investment Banking, Raymond James

Yehia Hashad, MD
Executive Vice President, R&D and Chief Medical Officer, Bausch + Lomb

Mike Hill
Managing Director, Octane Capital Markets

Allie Holmes
Senior Director of Marketing, Johnson & Johnson Vision, Surgical Vision

John Hovanesian, MD, FACS
Private Practice, Harvard Eye Associates, Laguna Hills, CA Clinical Faculty, UCLA Jules Stein Eye Institute, Los Angeles, CA

Kristen Ingenito, MBA
Vice President, Market Scope, LLC

Mark Kontos, MD
Empire Eye Physicians

Greg Kunst
Chief Executive Officer, Aurion Biotech

Baruch Kupperman, MD, Ph.D.
Steinert Endowed Professor, Chair, Department of Ophthalmology, Director, Gavin Herbert Eye Institute, University of California, Irvine

Mark Leahey
President & CEO, MDMA

David LeCause
Vice President – US Eye Care & Marketing, Allergan, an AbbVie Company

Richard Lindstrom, MD
Minnesota Eye Consultants

Norbert Lowe
Vice President, Head of Commercial, Eyenovia

Jim Mazzo
Executive Chairman, Neurotech
Co-Founder, Octane

Selina McGee, OD, FAAO
BeSpoke Vision

Cindy Metrose
Senior Director, Strategic Accounts and Digital Business, Zeiss

Yari Mitchell

Tom Mitro
Previous President, Aerie Pharmaceuticals

Aziz Mottiwala
Chief Commercial Officer, Tarsus Pharmaceuticals, Inc.

Jeffrey Nau, PhD.
President, Viatris Eye Care Division

Marc Odrich, MD
Chief Medical Officer, LENZ Therapeutics

Max Ostermeier
Founder & CEO, Implandata Ophthalmic Products

Jai G Parekh, MD, MBA
EVP/Chief Innovation Officer, EyeCheq
Founder, EyeCare Consultants of NJ

Leslie Patch, MD
Medical Director, Johnson & Johnson Vision

John Pollack, MD
Chief Medical Officer, jCyte, Inc.

Timothy Pratt, Ph.D.
Executive Director and Global Head Medical Device & Diagnostics Research, ICON

Sheri Rowen, MD, FACS
NVision Eye Centers

Ehsan Sadri, MD, FACS
CEO & Founder, Visionary Eye Institute

Luis Diaz Santana
Vice President Ophthalmology, Cambridge Consultants

Brent Saunders
Chairman and CEO, Bausch & Lomb

Omar Shakir, MD, MBA,
Coastal Eye Surgeons

Aimee Shimamoto
Director of Marketing, Americas, BVI

Kuldev Singh, MD, MPH
Professor of Ophthalmology and Director of the Glaucoma Service, Stanford University

Richard Small
CEO, Neurotech

Paul Smith
President & COO, Orasis Pharmaceuticals

Stephen Smith, MD
Founder & CEO, iRenix Medical, Inc.

Andrew Stewart
President, Ophthalmic Pharmaceuticals, Bausch + Lomb

Mike Sweeting
Founder & President, Viewpoint Therapeutics

Adam Szaronos
President & CEO, Trukera Medical

Ramin Valian
Vice President-US Eye Care

Luis G. Vargas, MD
Head Clinical Science, Johnson & Johnson Vision

John VeLure
CEO, I-Lumen

Marty Waters
Partner, Wilson Sonsini

Jeffry Weinhuff
Founder & Managing Partner, Visionary Venture Fund

James Williams
President & CEO, iOR Partners

Patrick Williams
Chief Financial Officer, STAAR Surgical

Elizabeth Yeu, MD
Partner, Virginia Eye Consultants

Dagny Zhu, MD
Medical Director and Partner, NVISION Eye Centers
